Clinical Trials Logo

Elderly clinical trials

View clinical trials related to Elderly.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06020742 Enrolling by invitation - Infertility, Female Clinical Trials

Automitochondrial Transplantation Improves Live Birth in Elderly Patients With Low Prognosis After Repeated IVF Failure

ACTILB
Start date: February 9, 2023
Phase: N/A
Study type: Interventional

The goal to this clinical trial is to study the effectiveness and safety of automitochondrial transplantation of urine derived stem cells(USCs) in in elderly patients with low prognosis after repeated IVF failure. The main questions it aims to answer are: (1)test the effectiveness and safety of automitochondrial transplantation of urine derived stem cells (2) establish intracytoplasmic sperm injection(ICSI) mitochondrial transplantation platform Participants will be asked to:1)urine collections to further culture of autologous USCs 2)ovarian stimulation、trigger eggs、ICSI with autologous mitochondria 3)embryo transfer 4)accept pregnancy follow-up at given point

NCT ID: NCT04971902 Enrolling by invitation - Pain Clinical Trials

Pharmacist-led Pharmacogenomic Clinical Service Within the Program of All-inclusive Care for the Elderly

Start date: July 1, 2021
Phase:
Study type: Observational

Pharmacist-led pharmacogenomics (PGx) clinical services and medication safety reviews are currently being offered to PACE organizations under the direction of licensed healthcare prescribers by CareKinesis d/b/a Tabula Rasa HealthCare. This project aims to include patients enrolled in PACE organizations with chronic pain and who are prescribed CYP2D6 activated opioids. PGx testing will be performed by contractual PGx vendor with TRHC. PGx results will be integrated into TRHC's proprietary Clinical Decision Support System (Medication Risk Mitigation™ Matrix, CareKinesis, Moorestown, NJ) that guides pharmacists to identify drug-drug interactions (DDIs), drug-gene interactions (DGIs), and drug-drug-gene interactions (DDGIs).16 Clinical pharmacists will translate PGx results combined with a comprehensive DDI review into actionable clinical decisions. Clinical pharmacists will provide medication therapy management recommendation to address medication problems to the PACE prescriber (physician). PACE prescribers will review the pharmacist's recommendation, and based on their clinical assessment, the prescriber will decide whether or not to implement the opioid therapy recommendation.

NCT ID: NCT03659175 Enrolling by invitation - Elderly Clinical Trials

Characteristic of Intestinal Flora in Male Elderly With Small Intestinal Bacterial Overgrowth

IFOSIBO
Start date: October 15, 2018
Phase:
Study type: Observational

We will focus on the intestinal flora structure, risk factors and clinical features of male elderly with SIBO in our study.

NCT ID: NCT00844025 Enrolling by invitation - Chronic Disease Clinical Trials

Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication

Start date: February 2009
Phase: N/A
Study type: Interventional

The investigators propose that clinical pharmacist interventions would reduce the rate of adverse drug events in elderly patients taking potentially inappropriate medication.